• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 18 Apr

    Auddia Announces Interim Bridge Financing; Withdraws Pending S-1 Registration Statement; Provides Details on M&A Initiatives

    Interim financing to bridge to advancement of ongoing buyside M&A discussions and anticipated favorable midyear performance metrics for faidr M&A strategy will accelerate Auddia's plans to scale, acquire subscribers, expand internationally, and deploy to broader platforms, including automobiles BOULDER, CO, April 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Auddia… Read More..

    Share this:
  • 18 Apr

    Lipella Pharmaceuticals Enters Manufacturing Collaboration Agreement with Cook MyoSite

    Lipella to collaborate in anticipation of forthcoming Investigational New Drug (IND) application LP-10 is a promising potential treatment for hemorrhagic cystitis that has received Orphan Drug Designation from the FDA Lipella has successfully completed a Phase 2a clinical trial evaluating LP-10 PITTSBURGH, April 17, 2023 /PRNewswire/ -- Lipella Pharmaceuticals Inc.… Read More..

    Share this:
  • 10 Apr

    LiveOne Prepares for PodcastOne Listing on a National Exchange Anticipated to Open at $8 to $12 Per Share – Expected Symbol “PDOC”

    - PodcastOne Repays $1 Million of Its Debt Convertible at $3 and Expects to Repay an Additional $1 Million to $2 Million - Extends Record Date to April 20, 2023 - Increases Dividend of PodcastOne Shares to LiveOne’s Shareholders of Record to Between 12% and 16% - LiveOne’s Buyback Exceeds… Read More..

    Share this:
« Previous 1 … 155 156 157 158 159 … 235 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact